A New Class of Immunotherapies Selecta is a clinical-stage biotechnology company developing novel drugs that use immune modulating nanomedicines to generate antigen-specific immune responses to prevent and treat disease. Our proprietary technology platform of Synthetic Vaccine Particles (SVP™) is a product engine for the durable and antigen-specific treatment of undesired immune responses. Our antigen-specific, tolerogenic SVPs can be applied in a variety of therapeutic areas with large unmet medical need, and we are strategically focused on three key applications: inhibition of immunogenicity for protein therapies, treatment of allergies, and treatment of autoimmune diseases. Through proprietary products and collaborations with leading pharmaceutical companies and research organizations, we are building a pipeline of product candidates to address unmet medical needs in serious and chronic diseases. Learn More News Profile June 17, 2014 – Selecta Accelerates Immune Tolerance Therapeutics and Announces New Product Candidate, SEL-212, for Refractory and Tophaceous Gout Read More June 17, 2014 – Selecta Biosciences Enters Into Exclusive License Agreement with 3SBio to Develop Drug Candidate to Treat Gout Read More June 17, 2014 – Selecta Biosciences to Accelerate Program for Novel Dual Action Vaccine for Malaria with support from the Bill & Melinda Gates Foundation Read More December 9, 2013 – Successful Pre-clinical Study of SEL-201 As An Antigen-Specific Immune Tolerance Treatment for Patients Receiving Factor VIII Therapy Read More December 9, 2013 – USPTO Allows First In a Series of Selecta Patents for Antigen-Specific Immune Tolerance Read More August 27, 2013 – Selecta Distinguished as World Economic Forum Technology Pioneer 2014 Read More September 6, 2011 – FierceBiotech Names Selecta Biosciences a 2011 Fierce 15 Biotech. Read More Job openings Controller Read More © 2014 Selecta Biosciences, Inc. | 480 Arsenal St., Building One, Watertown, MA 02472 | Phone: 617-923-1400 | Fax: 617-924-3454 | Email: info@selectabio.com Privacy Policy | Web site designed and developed by RainCastle Communications, Inc.